B cells and CD22 are dispensable for the immediate antiinflammatory activity of intravenous immunoglobulins in vivo (Q33403107)

26 July 2017

B cells and CD22 are dispensable for the immediate antiinflammatory activity of intravenous immunoglobulins in vivo (English)

1 reference

26 July 2017

Michaela Seeling

2

0 references

Markus Biburger

object named as

Markus Biburger

3

0 references

Falk Nimmerjahn

object named as

Falk Nimmerjahn

6

0 references

author name string

Inessa Schwab

1

1 reference

26 July 2017

Susanne Aschermann

4

1 reference

26 July 2017

Lars Nitschke

5

1 reference

26 July 2017

language of work or name

English

0 references

publication date

16 October 2012

1 reference

European Journal of Immunology

26 July 2017

1 reference

26 July 2017

42

1 reference

26 July 2017

12

1 reference

26 July 2017

3302-3309

1 reference

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood

26 July 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Intravenous immunoglobulin therapy in rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Intravenous immunoglobulin: an update on the clinical use and mechanisms of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Anti-inflammatory actions of intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

What is the contents of the magic draft IVIg?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Identification of a receptor required for the anti-inflammatory activity of IVIG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Mouse background and IVIG dosage are critical in establishing the role of inhibitory Fcγ receptor for the amelioration of experimental ITP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Intravenous immunoglobulin up-regulates the expression of the inhibitory FcgammaIIB receptor on B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

B cells regulate autoimmunity by provision of IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Immune regulatory function of B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of Toll-like receptors in immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

TLR9 responses of B cells are repressed by intravenous immunoglobulin through the recruitment of phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Intravenous immunoglobulin preparations have no direct effect on B cell proliferation and immunoglobulin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Monocyte subsets responsible for immunoglobulin G-dependent effector functions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Arthritis critically dependent on innate immune system players

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

The role of differential IgG glycosylation in the interaction of antibodies with FcγRs in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

New insight into the mechanism of action of IVIg: the role of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Analysis and functional consequences of increased Fab-sialylation of intravenous immunoglobulin (IVIG) after lectin fractionation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Mechanisms of IVIG efficacy in chronic inflammatory demyelinating polyneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

A close look at human IgG sialylation and subclass distribution after lectin fractionation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

The role of sialic acid as a modulator of the anti-inflammatory activity of IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Distinct cell-specific control of autoimmunity and infection by FcgammaRIIb

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

DC-SIGN: escape mechanism for pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

FcgammaRIV: a novel FcR with distinct IgG subclass specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Divergent immunoglobulin g subclass activity through selective Fc receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: A mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

Impact of a Three Amino Acid Deletion in the CH2 Domain of Murine IgG1 on Fc-Associated Effector Functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

FcγRIIb controls bone marrow plasma cell persistence and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

7 January 2021

Inhibition of B cell-mediated antigen presentation by intravenous immunoglobulins (IVIg)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

7 January 2021

Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

7 January 2021

The inhibiting Fc receptor for IgG, FcγRIIB, is a modifier of autoimmune susceptibility

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242710

7 January 2021

Identifiers

DOI

10.1002/EJI.201242710

1 reference

26 July 2017

1 reference